Transgene Appoints Banker and Nobel Prize Winner to Board | GenomeWeb

STRASBOURG, France--Paul Berg, director of the Beckman Center for Molecular and Genetic Research at Stanford University School of Medicine, and G. Steven Burrill, CEO of Burrill & Company, a private merchant bank specializing in life sciences companies, have joined the board of directors at integrated biotech firm Transgene here.

Winner of the Nobel Prize for chemistry in 1980 for his studies of the biochemistry of nucleic acids with a specific emphasis on recombinant DNA, Berg will also participate in meetings of Transgene's scientific board.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.